Clinical Trial: (Gastrografin Use in Small Bowel Obstruction Caused by Adherences)
Study Status: Completed
Recruit Status: Completed
Study Type: Interventional
Official Title: Gastrografin Use in Small Bowel Obstruction Caused by Adherences
Brief Summary:
Adhesive small intestine obstruction (ASIO) is an important cause of hospital admission and a very common disease. Any improvement in this field will benefit many patients by reducing the operative rate. Patients with this disease are difficult to evaluate and to manage and their treatment is controversial. Emergency surgery is mandatory when strangulation is suspected or in the case of total obstruction. On the other hand, conservative non-operative treatment is indicated in the case of partial obstruction. The role of water-soluble contrast medium (Gastrografin®: GG) in ASIO is still debated with regard to the therapeutic value.
The aim of our study was to determine the therapeutic role of Gastrografin in patients with small intestine obstruction without strangulation caused by adherences (ASIO).
Detailed Summary:
Sponsor: University of Bologna
Current Primary Outcome: The operative rate in ASIO patients [ Time Frame: Within 72 hours and during hospital stay ]
Original Primary Outcome: Same as current
Current Secondary Outcome:
- The incidence of major and minor complications of treatments in the two arm [ Time Frame: 1 year ]
- The ASIO recurrences [ Time Frame: 1 year ]
- The time to resolution of obstruction [ Time Frame: Within hospital stay ]
- The length of hospital stay [ Time Frame: Within hospital admission period ]
Original Secondary Outcome: Same as current
Information By: University of Bologna
Dates:
Date Received: January 14, 2008
Date Started: September 2003
Date Completion:
Last Updated: January 25, 2008
Last Verified: January 2008
